Effects of left atrial enlargment on the recurrence of atrial fibrillation in elderly paroxysm alatrial fibrillation patients after pacemaker implantation

doi:10.12047/j.cjap.5493.2017.063

Abstract

Abstract: Objective: To investigate the incidence of recurrent atrial fibrillation, including asymptomatic atrial fibrillation, and the effect of left atrial volume index (LAVI) on recurrence of atrial fibrillation in elderly paroxysmal atrial fibrillation patients with implanted cardiac pacemakers. Methods: One hundred and forty eight elderly paroxysmal atrial fibrillation patients without antiarrhythmic drug therapy after car-diac pacemaker implantation were selected from January 2012 to December 2013 in this study. The baseline characteristics, echocardiography parameters, the incidence of recurrent atrial fibrillation and the burden of atrial fibrillation were recorded. The patients were divided into groups according to the burden of atrial fibrillation and the left atrial volume index. Multivariate Cox regression analysis was adopted to calculate the adjusted hazard ratio (HR) of left atrial volume index for the device-detected recurrence of atrial fibrillation and atrial fibrillation burden. Results: During an average of 22.79 months follow-up period, 57.43% of the patients with recurrence of atrial fibrillation, 22.97% of the pa-tients with high intensity burden of atrial fibrillation, and 15.54% of the patients with asymptomatic atrial fibrillation were found. Multivariate Cox regression analysis demonstrated left atrial enlargement (LAVI > 28 ml/m²) was an independent risk factor for the device-detected recur-rence of atrial fibrillation (P < 0.05) and atrial fibrillation burden (P < 0.01)respectively. Conclusion: Left atrial volume index is an inde-pendent risk factor for the recurrence of atrial fibrillation and atrial fibrillation burden in elderly patients with paroxysmal atrial fibrillation after pacemaker implantation.

Key words: cardiac pacemaker, paroxysmal atrial fibrillation, left atrial volume index, elder

WANG Hai-jun, SHI Yang, LI Jian, SI Quan-jin, WANG Yu-tang. Effects of left atrial enlargment on the recurrence of atrial fibrillation in elderly paroxysm alatrial fibrillation patients after pacemaker implantation[J]. CJAP, 2017, 33(3): 257-261.

References

[1] Cabrera S, Mercé J, de Castro R, et al. Pacemaker clinic:an opportunity to detect silent atrial fibrillation and improve antithrombotic treatment[J]. Europace, 2011, 13(11):1574-1579.
[2] Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke[J]. N Engl J Med, 2012, 366(2):120-129.
[3] Sciacqua A, Perticone M, Tripepi G, et al. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors[J]. Int J Cardiol, 2014, 175(1):90-95.
[4] Gonzalez M, Keating RJ, Markowitz SM, et al. Newly de-tected atrial high rate episodes predict long-term mortality out-comes in patients with permanent pacemakers[J]. Heart Rhythm, 2014, 11(12):2214-2221.
[5] Boriani G, Glotzer TV, Santini M, et al. Device-detected a-trial fibrillation and risk for stroke:an analysis of > 10, 000 patients from the SOS AF project (Stroke preventiOn Strate-gies based on Atrial Fibrillation information from implanted devices)[J]. Eur Heart J, 2014, 35(8):508-516.
[6] Mittal S, Stein K, Gilliam FR 3rd, et al. Frequency, dura-tion, and predictors of newly-diagnosed atrial fibrillation fol-lowing dual-chamber pacemaker implantation in patients with-out a previous history of atrial fibrillation[J]. Am J Cardiol, 2008, 102(4):450-453.
[7] Fleischmann KE, Orav EJ, Lamas GA, et al. Atrial fibrilla-tion and quality of life after pacemaker implantation for sick sinus syndrome:data from the Mode Selection Trial (MOST)[J]. Am Heart J, 2009, 158(1):78-83.
[8] Khurram IM, Maqbool F, Berger RD, et al. Association Be-tween Left Atrial Stiffness Index and Atrial Fibrillation Recur-rence in Patients Undergoing Left Atrial Ablation[J]. Circ Arrhythm Electrophysiol, 2016, 9(3):e003163.
[9] Park J, Yang PS, Kim TH, et al. Low Left Atrial Compli-ance Contributes to the Clinical Recurrence of Atrial Fibrilla-tion after Catheter Ablation in Patients with Structurally and Functionally Normal Heart[J]. PLoS One, 2015, 10(12):e0143853.
[10] January CT, Wann LS, Alpert JS, et al. 2014AHA/ACC/HRS guideline for the management of patients with atrial fib-rillation:executive summary:a report of the American Col-lege of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circu-lation, 2014, 130(23):2071-2104.
[11] Krishnamoorthy S, Khoo CW, Lim HS, et al. Predictive value of atrial high-rate episodes for arterial stiffness and en-dothelial dysfunction in dual-chamber pacemaker patients[J]. Eur J Clin Invest, 2014, 44(1):13-21.
[12] Kaireviciute D, Lip GY, Balakrishnan B, et al. Intracardiac expression of markers of endothelial damage/dysfunction, in-flammation, thrombosis, and tissue remodeling, and the de-velopment of postoperative atrial fibrillation[J]. J Thromb Haemost, 2011, 9(12):2345-2352.
[13] Gasparovic H, Cikes M, Kopjar T, et al. Atrial apoptosis and fibrosis adversely affect atrial conduit, reservoir and con-tractile functions[J]. Interact Cardiovasc Thorac Surg, 2014, 19(2):223-230.